Noble gases as cardioprotectants - Translatability and mechanism

British Journal of Pharmacology

Volumn 172, Issue 8, 2015, Pages 2062-2073

  Smit, Kirsten F ^a   Weber, Nina C ^a   Hollmann, Markus W ^a   Preckel, Benedikt ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON; CAVEOLIN; CYCLOOXYGENASE 2; HELIUM; INERT GAS; INTERCELLULAR ADHESION MOLECULE 1; KRYPTON; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEON; PROPOFOL; PROTECTIVE AGENT; PROTEIN KINASE C; SEVOFLURANE; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; XENON; CARDIOTONIC AGENT;

ANTIINFLAMMATORY ACTIVITY; CARDIOPULMONARY BYPASS; CAVEOLA; CORONARY ARTERY BYPASS SURGERY; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INDUCED HYPOTHERMIA; NEUROPROTECTION; NONHUMAN; OUT OF HOSPITAL CARDIAC ARREST; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; ANIMAL;

ANIMALS; CARDIOTONIC AGENTS; HELIUM; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; XENON;

EID: 84925867499     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12994     Document Type: Review

References (102)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol. 170: 1449-1458.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol. 170: 1459-1581.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Ligand-gated ion channels. Br J Pharmacol. 170: 1582-1606.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013d). The Concise Guide to PHARMACOLOGY 2013/14: Ion channels. Br J Pharmacol. 170: 1607-1651.
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013e). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic receptors. Br J Pharmacol. 170: 1676-1705.
6. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013f). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol. 170: 1797-1867.
7. Arola OJ, Laitio RM, Roine RO, Grönlund J, Saraste A, Pietilä M, et al. (2013). Feasibility and cardiac safety of inhaled xenon in combination with therapeutic hypothermia following out-of-hospital cardiac arrest. Crit Care Med 41: 2116-2124.
8. Bantel C, Maze M, Trapp S, (2009). Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 110: 986-995.
9. Baumert J-H, Hein M, Hecker KE, Satlow S, Neef P, Rossaint R, (2008). Xenon or propofol anaesthesia for patients at cardiovascular risk in non-cardiac surgery. Br J Anaesth 100: 605-611.
10. Baumert JH, Falter F, Eletr D, Hecker KE, Reyle-Hahn M, Rossaint R, (2005). Xenon anaesthesia may preserve cardiovascular function in patients with heart failure. Acta Anaesthesiol Scand 49: 743-749.
11. Bedi A, McBride WT, Armstrong MA, Murray JM, Fee JPH, (2002). Xenon has no effect on cytokine balance and adhesion molecule expression within an isolated cardiopulmonary bypass system. Br J Anaesth 89: 546-550.
12. Bein B, Turowski P, Renner J, Hanss R, Steinfath M, Scholz J, et al. (2005). Comparison of xenon-based anaesthesia compared with total intravenous anaesthesia in high risk surgical patients. Anaesthesia 60: 960-967.
13. Bein B, Renner J, Caliebe D, Hanss R, Bauer M, Fraund S, et al. (2008). The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol. Anaesthesia 63: 1046-1055.
14. Brevoord D, Beurskens C, Juffermans N, van den Bergh W, Preckel B, Horn J, (2012). Helium ventilation is safe and feasible in ICU patients admitted after cardiac arrest. Eur J Anaesthesiol 29 (Suppl.): 192.
15. Bronco A, Ingelmo PM, Aprigliano M, Turella M, Sahillioʇlu E, Bucciero M, et al. (2010). Xenon anaesthesia produces better early postoperative cognitive recovery than sevoflurane anaesthesia. Eur J Anaesthesiol 27: 912-916.
16. Clark JA, Ma D, Homi HM, Maze M, Grocott HP, (2005). Xenon and the inflammatory response to cardiopulmonary bypass in the rat. J Cardiothorac Vasc Anesth 19: 488-493.
17. Coburn M, Kunitz O, Baumert J-H, Hecker K, Haaf S, Zühlsdorff A, et al. (2005). Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth 94: 198-202.
18. Coburn M, Baumert J-H, Roertgen D, Thiel V, Fries M, Hein M, et al. (2007). Emergence and early cognitive function in the elderly after xenon or desflurane anaesthesia: a double-blinded randomized controlled trial. Br J Anaesth 98: 756-762.
19. Coburn M, Sanders RD, Ma D, Fries M, Rex S, Magalon G, et al. (2012). Argon: the 'lazy' noble gas with organoprotective properties. Eur J Anaesthesiol 29: 549-551.
20. Cohen MV, Yang X-M, Downey JM, (2007). The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115: 1895-1903.
21. Colloc'h N, Sopkova-de Oliveira Santos J, Retailleau P, Vivarès D, Bonneté F, Langlois d'Estainto B, et al. (2007). Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys J 92: 217-224.
22. Cremer J, Stoppe C, Fahlenkamp AV, Schälte G, Rex S, Rossaint R, et al. (2011). Early cognitive function, recovery and well-being after sevoflurane and xenon anaesthesia in the elderly: a double-blinded randomized controlled trial. Med Gas Res 1: 9.
23. Cullen SC, Gross EG, (1951). The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 113: 580-582.
24. David HN, Haelewyn B, Risso J-J, Abraini JH, (2012). Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator. Naunyn Schmiedebergs Arch Pharmacol 386: 91-95.
25. Deng J, Lei C, Chen Y, Fang Z, Yang Q, Zhang H, et al. (2014). Neuroprotective gases-fantasy or reality for clinical use? Prog Neurobiol 115: 210-245.
26. Dickinson R, Peterson BK, Banks P, Simillis C, Martin JCS, Valenzuela CA, et al. (2007). Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology. Anesthesiology 107: 756-767.
27. Dingley J, Mason RS, (2007). A cryogenic machine for selective recovery of xenon from breathing system waste gases. Anesth Analg 105: 1312-1318.
28. Fahlenkamp AV, Coburn M, Haase H, Kipp M, Ryang Y-M, Rossaint R, et al. (2010). Xenon enhances LPS-induced IL-1β expression in microglia via the extracellular signal-regulated kinase 1/2 pathway. J Mol Neurosci 45: 48-59.
29. Fahlenkamp AV, Rossaint R, Haase H, Al Kassam H, Ryang Y-M, Beyer C, et al. (2012). The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur J Pharmacol 674: 104-111.
30. Fahlenkamp AV, Coburn M, Rossaint R, Stoppe C, Haase H, (2014). Comparison of the effects of xenon and sevoflurane anaesthesia on leucocyte function in surgical patients: a randomized trial. Br J Anaesth 112: 272-280.
31. Franks NP, Dickinson R, De Sousa S, Hall NA, Lieb WR, (1998). How does xenon produce anaesthesia? Nature 396: 324.
32. Frässdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann T, et al. (2009). Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg 137: 1436-1442.
33. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP, (2004). Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65: 443-452.
34. Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R, (2013). Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-Methyl-D-Aspartate receptor glycine site. Anesthesiology 119: 1137-1148.
35. Harris PD, Barnes R, (2008). The uses of helium and xenon in current clinical practice. Anaesthesia 63: 284-293.
36. Hausenloy DJ, Ong S-B, Yellon DM, (2009). The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104: 189-202.
37. Hausenloy DJ, Lecour S, Yellon DM, (2011). Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14: 893-907.
38. Heinen A, Huhn R, Smeele KMA, Zuurbier CJ, Schlack W, Preckel B, et al. (2008). Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2+)-sensitive potassium channel activation. Anesthesiology 109: 830-836.
39. Hofland J, (2014). Xenon compared to sevoflurane and total intravenous anaesthesia for coronary artery bypass graft surgery. ClinicalTrials.gov. NCT01294163: 1-3.
40. Horikawa YT, Patel HH, Tsutsumi YM, Jennings MM, Kidd MW, Hagiwara Y, et al. (2008). Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol 44: 123-130.
41. Höcker J, Stapelfeldt C, Leiendecker J, Meybohm P, Hanss R, Scholz J, et al. (2009). Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofol anesthesia for major noncardiac surgery: a double-blinded randomized controlled pilot study. Anesthesiology 110: 1068-1076.
42. Huhn R, Heinen A, Weber NC, Hieber S, Hollmann MW, Schlack W, et al. (2009a). Helium-induced late preconditioning in the rat heart in vivo. Br J Anaesth 102: 614-619.
43. Huhn R, Heinen A, Weber NC, Kerindongo RP, Oei GTML, Hollmann MW, et al. (2009b). Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo. J Pharmacol Exp Ther 329: 600-607.
44. Huhn R, Weber NC, Preckel B, Schlack W, Bauer I, Hollmann MW, et al. (2012). Age-related loss of cardiac preconditioning: impact of protein kinase A. Exp Gerontol 47: 116-121.
45. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, et al. (2009). Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 460: 232-236.
46. Limatola V, Ward P, Cattano D, Gu J, Giunta F, Maze M, et al. (2010). Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion. Neuroscience 165: 874-881.
47. Lockwood GG, Franks NP, Downie NA, Taylor KM, Maze M, (2006). Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study. Anesthesiology 104: 458-465.
48. Lucchinetti E, Wacker J, Maurer C, Keel M, Härter L, Zaugg K, et al. (2009). Helium breathing provides modest antiinflammatory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo. Anesth Analg 109: 101-108.
49. Ma D, Lim T, Xu J, Tang H, Wan Y, Zhao H, et al. (2009). Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 20: 713-720.
50. Oei G, Heger M, van Golen RF, Preckel B, Hollmann MW, Weber NC, (2013). Transcriptional regulation of cardiac cell death and survival signaling by helium postconditioning in a rat model of regional cardiac ischemia/reperfusion. FASEB J 27 (Meeting Abstract Suppl.): lb623.
51. Oei GTML, Smit KF, vander Vondervoort D, Brevoord D, Hoogendijk A, Wieland CW, et al. (2012a). Effects of helium and air inhalation on the innate and early adaptive immune system in healthy volunteers ex vivo. J Transl Med 10: 201.
52. Oei GTML, Weber NC, Hollmann MW, Preckel B, (2010). Cellular effects of helium in different organs. Anesthesiology 112: 1503-1510.
53. Oei GTML, Huhn R, Heinen A, Hollmann MW, Schlack WS, Preckel B, et al. (2012b). Helium-induced cardioprotection of healthy and hypertensive rat myocardium in vivo. Eur J Pharmacol 684: 125-131.
54. O'Rourke B, (2004). Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res 94: 420-432.
55. Pagel PS, (2010). Cardioprotection by noble gases. J Cardiothorac Vasc Anesth 24: 143-163.
56. Pagel PS, Krolikowski JG, (2009). Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits. Anesth Analg 108: 1076-1082.
57. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, et al. (2007). Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 105: 562-569.
58. Pagel PS, Krolikowski JG, Pratt PF Jr, Shim YH, Amour J, Warltier DC, et al. (2008a). Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition. Anesth Analg 107: 769-775.
59. Pagel PS, Krolikowski JG, Pratt PF, Shim YH, Amour J, Warltier DC, et al. (2008b). Reactive oxygen species and mitochondrial adenosine triphosphate-regulated potassium channels mediate helium-induced preconditioning against myocardial infarction in vivo. J Cardiothorac Vasc Anesth 22: 554-559.
60. Pagel PS, Krolikowski JG, Pratt PF, Shim YH, Amour J, Warltier DC, et al. (2008c). The mechanism of helium-induced preconditioning: a direct role for nitric oxide in rabbits. Anesth Analg 107: 762-768.
61. Pagel PS, Krolikowski JG, Amour J, Warltier DC, Weihrauch D, (2009). Morphine reduces the threshold of helium preconditioning against myocardial infarction: the role of opioid receptors in rabbits. J Cardiothorac Vasc Anesth 23: 619-624.
62. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-1106.
63. Petzelt C, Taschenberger G, Schmehl W, Kox WJ, (1999). Xenon-induced inhibition of Ca2+-regulated transitions in the cell cycle of human endothelial cells. Pflugers Arch 437: 737-744.
64. Preckel B, Schlack W, Obal D, Barthel H, Ebel D, Grunert S, et al. (1998). Effect of acidotic blood reperfusion on reperfusion injury after coronary artery occlusion in the dog heart. J Cardiovasc Pharmacol 31: 179-186.
65. Preckel B, Müllenheim J, Moloschavij A, Thämer V, Schlack W, (2000). Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 91: 1327-1332.
66. Preckel B, Ebel D, Müllenheim J, Frässdorf J, Thämer V, Schlack W, (2002a). The direct myocardial effects of xenon in the dog heart in vivo. Anesth Analg 94: 545-551.
67. Preckel B, Schlack W, Heibel T, Rütten H, (2002b). Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function. Br J Anaesth 88: 264-269.
68. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W, (2006). Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 105: 187-197.
69. Przyklenk K, (2013). Reduction of myocardial infarct size with ischemic 'conditioning'. Anesth Analg 117: 891-901.
70. Rasmussen LS, Schmehl W, Jakobsson J, (2006). Comparison of xenon with propofol for supplementary general anaesthesia for knee replacement: a randomized study. Br J Anaesth 97: 154-159.
71. Rassaf T, Totzeck M, Hendgen-Cotta UB, Shiva S, Heusch G, Kelm M, (2014). Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res 114: 1601-1610.
72. Rawat S, Dingley J, (2010). Closed-circuit xenon delivery using a standard anesthesia workstation. Anesth Analg 110: 101-109.
73. Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, Ma D, (2010). Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med (Maywood) 235: 886-891.
74. Rodrigo G, Pollack C, Rodrigo C, Rowe B, (2002). Heliox for treatment of exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2): CD003571.
75. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, Scholz J, Scherpereel P, Vallet B, et al. (2003). Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 98: 6-13.
76. de Rossi LW, Brueckmann M, Rex S, Barderschneider M, Buhre W, Rossaint R, (2004). Xenon and isoflurane differentially modulate lipopolysaccharide-induced activation of the nuclear transcription factor KB and production of tumor necrosis factor-alpha and interleukin-6 in monocytes. Anesth Analg 98: 1007-1012.
77. Ryang Y-M, Fahlenkamp AV, Rossaint R, Wesp D, Loetscher PD, Beyer C, et al. (2011). Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 39: 1448-1453.
78. Saravanan P, Exley AR, Valchanov K, Casey ND, Falter F, (2009). Impact of xenon anaesthesia in isolated cardiopulmonary bypass on very early leucocyte and platelet activation and clearance: a randomized, controlled study. Br J Anaesth 103: 805-810.
79. Schaefer W, Meyer PT, Rossaint R, Baumert JH, Coburn M, Fries M, et al. (2011). Myocardial blood flow during general anesthesia with xenon in humans: a positron emission tomography study. Anesthesiology 114: 1373-1379.
80. Schwiebert C, Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, et al. (2010). Postconditioning by xenon and hypothermia in the rat heart in vivo. Eur J Anaesthesiol 27: 734-739.
81. Simkhovich BZ, Przyklenk K, Kloner RA, (2013). Role of protein kinase C in ischemic 'conditioning': from first evidence to current perspectives. J Cardiovasc Pharmacol Ther 18: 525-532.
82. Smit KF, Brevoord D, De Hert SG, Hollmann MW, Weber NC, Preckel B, (2012). Helium induced pre- and postconditioning in patients subjected to coronary artery bypass graft (CABG) surgery. Eur J Anaesthesiol 29 (Suppl.): 53.
83. Smit KF, Oei GTML, Brevoord D, Stroes ES, Nieuwland R, Schlack WS, et al. (2013). Helium induces preconditioning in human endothelium in vivo. Anesthesiology 118: 95-104.
84. Spaggiari S, Kepp O, Rello-Varona S, Chaba K, Adjemian S, Pype J, et al. (2013). Antiapoptotic activity of argon and xenon. Cell Cycle 12: 2636-2642.
85. Stoppe C, Fahlenkamp AV, Rex S, Veeck NC, Gozdowsky SC, Schälte G, et al. (2013). Feasibility and safety of xenon compared with sevoflurane anaesthesia in coronary surgical patients: a randomized controlled pilot study. Br J Anaesth 111: 406-416.
86. Stuttmann R, Jakubetz J, Schultz K, Schäfer C, Langer S, Ullmann U, et al. (2010). Recovery index, attentiveness and state of memory after xenon or isoflurane anaesthesia: a randomized controlled trial. BMC Anesthesiol 10: 5.
87. Suzuki T, Koyama H, Sugimoto M, Uchida I, Mashimo T, (2002). The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine 3 receptors expressed in xenopus oocytes. Anesthesiology 96: 699-704.
88. Vorwerk C, Coats T, (2010). Heliox for croup in children. Cochrane Database Syst Rev (2): CD006822.
89. Wappler F, Rossaint R, Baumert J, Scholz J, Tonner PH, van Aken H, et al. (2007). Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology 106: 463-471.
90. Weber NC, Toma O, Wolter JI, Obal D, Müllenheim J, Preckel B, et al. (2005a). The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 144: 123-132.
91. Weber NC, Toma O, Wolter JI, Wirthle NM, Schlack W, Preckel B, (2005b). Mechanisms of xenon- and isoflurane-induced preconditioning-a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Br J Pharmacol 146: 445-455.
92. Weber NC, Stursberg J, Wirthle NM, Toma O, Schlack W, Preckel B, (2006a). Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Br J Anaesth 97: 298-306.
93. Weber NC, Toma O, Damla H, Wolter JI, Schlack W, Preckel B, (2006b). Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1. Eur J Pharmacol 539: 1-9.
94. Weber NC, Frässdorf J, Ratajczak C, Grueber Y, Schlack W, Hollmann MW, et al. (2008a). Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2? Anesth Analg 107: 1807-1813.
95. Weber NC, Goletz C, Huhn R, Grueber Y, Preckel B, Schlack W, et al. (2008b). Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases. Eur J Pharmacol 592: 48-54.
96. Weber NC, Kandler J, Schlack W, Grueber Y, Frädorf J, Preckel B, (2008c). Intermitted pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells. Anesthesiology 108: 199-207.
97. Weber NC, vander Vondervoort D, Niesman IR, Saldana M, Roth DM, Preckel B, et al. (2012). Effects of noble gas conditioning on caveolin expression in the rat heart in vivo. FASEB J 28: 1114.17.
98. Weber NC, Schilling JM, Finley JC, Irvine M, Kellerhals SE, Niesman IR, et al. (2013). Helium inhalation induces caveolin secretion to blood. FASEB J 27 (Meeting Abstract Suppl.): 1089.3.
99. Yamakura T, Harris RA, (2000). Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 93: 1095-1101.
100. Yamamoto Y, Kawaguchi M, Kurita N, Kakimoto M, Inoue S, Furuya H, (2010). Effects of xenon on ischemic spinal cord injury in rabbits: a comparison with propofol. Acta Anaesthesiol Scand 54: 337-342.
101. Yang YW, Cheng WP, Lu JK, Dong XH, Wang CB, Zhang J, et al. (2013). Timing of xenon-induced delayed postconditioning to protect against spinal cord ischaemia-reperfusion injury in rats. Br J Anaesth 113: 168-176.
102. Zhao H, Yoshida A, Xiao W, Ologunde R, O'Dea KP, Takata M, et al. (2013). Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats. FASEB J 27: 4076-4088.